Literature DB >> 18363585

Cutaneous leishmaniasis in the Jordanian side of the Jordan Valley: severe under-reporting and consequences on public health management.

Ibrahim M Mosleh1, Eid Geith, Lina Natsheh, Muna Abdul-Dayem, Nabil Abotteen.   

Abstract

OBJECTIVE: To test if cutaneous leishmaniasis (CL) is under-reported in the Jordanian Mid Jordan Valley, with resultant serious consequences for drug supply.
METHODS: For 2001-2003, prescribed amounts of drug and laboratory log-books were investigated to estimate CL cases reported in Jordanian Mid Jordan Valley. From April 2004 to May 2005, passive detection and focused active 'index case cluster'-directed detection were used.
RESULTS: An average of 75/100,000 cases per year was estimated to have occurred 2001-2003, resulting in under-reporting by a factor of 47. In 2004/2005, 313/100,000 cases per year were passively detected. Active case-finding detected additional cases.
CONCLUSION: Cutaneous leishmaniasis is severely under-reported in Jordanian Mid Jordan Valley, which impacts its eradication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363585     DOI: 10.1111/j.1365-3156.2008.02063.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  18 in total

1.  Human immune response to salivary proteins of wild-caught Phlebotomus papatasi.

Authors:  Rami M Mukbel; Rehab H Khasharmeh; Nawal S Hijjawi; Mohammed S Khalifeh; Ma'mon M Hatmal; Mary Ann McDowell
Journal:  Parasitol Res       Date:  2016-05-10       Impact factor: 2.289

2.  Assessment of a Leishmaniasis Reporting System in Tropical Bolivia Using the Capture-Recapture Method.

Authors:  Daniel Eid; Miguel Guzman-Rivero; Ernesto Rojas; Isabel Goicolea; Anna-Karin Hurtig; Daniel Illanes; Miguel San Sebastian
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

Review 3.  Leishmaniasis: new insights from an old and neglected disease.

Authors:  S Antinori; L Schifanella; M Corbellino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

4.  Detection, genotyping, and phylogenetic analysis of Leishmania isolates collected from infected Jordanian residents and Syrian refugees who suffered from cutaneous leishmaniasis.

Authors:  Kamal J F Hijawi; Nawal S Hijjawi; Jwan H Ibbini
Journal:  Parasitol Res       Date:  2019-02-07       Impact factor: 2.289

5.  Integration of phlebotomine ecological niche modelling, and mapping of cutaneous leishmaniasis surveillance data, to identify areas at risk of under-estimation.

Authors:  Clara B Ocampo; Lina Guzmán-Rodríguez; Mabel Moreno; María Del Mar Castro; Carlos Valderrama-Ardila; Neal Alexander
Journal:  Acta Trop       Date:  2021-09-02       Impact factor: 3.222

6.  Leishmania major cutaneous leishmaniasis outbreak in the Jordanian side of the Northern Jordan Valley.

Authors:  Ibrahim M Mosleh; Gabrielle Schönian; Khalil Kanani; Bassam Shadfan
Journal:  Pathog Glob Health       Date:  2018-02-02       Impact factor: 2.894

7.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

8.  Resurgence of cutaneous leishmaniasis in Israel, 2001-2012.

Authors:  Dan Gandacu; Yael Glazer; Emilia Anis; Isabella Karakis; Bruce Warshavsky; Paul Slater; Itamar Grotto
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

9.  Endemic characteristics of infantile visceral leishmaniasis in the People's Republic of China.

Authors:  Qing Fu; Shi-Zhu Li; Wei-Ping Wu; Yan-Yan Hou; Song Zhang; Yu Feng; Li-Ping Zhang; Lin-Hua Tang
Journal:  Parasit Vectors       Date:  2013-05-17       Impact factor: 3.876

10.  Use of Capture-Recapture to Estimate Underreporting of Ebola Virus Disease, Montserrado County, Liberia.

Authors:  Etienne Gignoux; Rachel Idowu; Luke Bawo; Lindis Hurum; Armand Sprecher; Mathieu Bastard; Klaudia Porten
Journal:  Emerg Infect Dis       Date:  2015-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.